Correlation Between Relief Therapeutics and Defence Therapeutics

Can any of the company-specific risk be diversified away by investing in both Relief Therapeutics and Defence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relief Therapeutics and Defence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Relief Therapeutics Holding and Defence Therapeutics, you can compare the effects of market volatilities on Relief Therapeutics and Defence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relief Therapeutics with a short position of Defence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relief Therapeutics and Defence Therapeutics.

Diversification Opportunities for Relief Therapeutics and Defence Therapeutics

0.0

Correlation Coefficient

Relief Therapeutics  Defence Therapeutics

Pay attention - limited upside

The 3 months correlation between Relief and Defence is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Relief Therapeutics Holding and Defence Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Defence Therapeutics and Relief Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relief Therapeutics Holding are associated (or correlated) with Defence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Defence Therapeutics has no effect on the direction of Relief Therapeutics i.e., Relief Therapeutics and Defence Therapeutics go up and down completely randomly.

Pair Corralation between Relief Therapeutics and Defence Therapeutics

Assuming the 90 days horizon Relief Therapeutics Holding is expected to generate 2.41 times more return on investment than Defence Therapeutics. However, Relief Therapeutics is 2.41 times more volatile than Defence Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Defence Therapeutics is currently generating about -0.12 per unit of risk. If you would invest  257.00  in Relief Therapeutics Holding on September 21, 2024 and sell it today you would earn a total of  223.00  from holding Relief Therapeutics Holding or generate 86.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Relief Therapeutics Holding  vs.  Defence Therapeutics

Relief Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Relief Therapeutics Holding are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Relief Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Defence Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Defence Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Relief Therapeutics and Defence Therapeutics

The main advantage of trading using opposite Relief Therapeutics and Defence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relief Therapeutics position performs unexpectedly, Defence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Defence Therapeutics will offset losses from the drop in Defence Therapeutics' long position.

The idea behind Relief Therapeutics Holding and Defence Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.